Biofabri is a Spanish biopharmaceutical company founded in 2008 based on a legacy of more than 70 years' experience in the pharmaceutical industry. Its main activity focuses on the research&development and industrial production of vaccines for human use and the contract manufacturing and distribution (CDMO) of pharmaceutical products. Our most advanced project is a vaccine against Tuberculosis (at phase Ib), that is being developed in collaboration with the University of Zaragoza, Pasteur Institute and TB Vaccine Initiative. We count with a valuable infrastructure and knowledge to address biotech projects from a laboratory stage to a large scale production. Biofabri is a company of Zendal group, a bioparmecutical group focsed on vaccines and biotechnology.